• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

姑息治疗与血液系统恶性肿瘤:综合癌症中心的转诊量增加。

Palliative care and hematological malignancies: increased referrals at a comprehensive cancer centre.

机构信息

Palliative Care Service, Alfred Hospital, Prahan, Victoria, Australia.

出版信息

J Palliat Med. 2013 May;16(5):537-41. doi: 10.1089/jpm.2012.0377.

DOI:10.1089/jpm.2012.0377
PMID:23822210
Abstract

BACKGROUND

Current evidence indicates that patients with hematological malignancies are less likely to receive input from specialist palliative care services compared to those with solid tumors.

AIM

We aimed to analyze data for referrals to our palliative care service, in order to assess trends in the number and proportion of referrals received from hematology, and changes in the characteristics of these referrals.

DESIGN

Prospective information was collected for all referrals to the Department of Pain and Palliative Care (DPPC) over a four-year period. This included inpatient/outpatient status, diagnosis, symptoms, and goals of the referring clinician; and information linked to hospital inpatient data to obtain date and location of death.

SETTINGS/PARTICIPANTS: All hematology referrals were from January 2007 to December 2010.

RESULTS

Hematology referrals constituted 11.6% of all referrals received during the study period. Outpatient referrals increased significantly with each year, as did the proportion of patients referred for symptom control. The median time from referral to death was 34 days, with poorest survival seen in acute leukemia and inpatients. Overall, 54% of inpatient hematology deaths had consultation from the DPPC, with these patients less likely to die in the intensive care unit.

CONCLUSIONS

Over recent years, collaboration between hematology and palliative care has resulted in increased referral numbers, with potentially positive results for patients.

摘要

背景

目前的证据表明,与实体瘤患者相比,血液系统恶性肿瘤患者接受专业姑息治疗服务的可能性较小。

目的

我们旨在分析向我们姑息治疗服务转诊的数据,以评估来自血液科的转诊数量和比例的趋势,并评估这些转诊的特征变化。

设计

前瞻性地收集了 DPPC(疼痛和姑息治疗科)在四年期间的所有转诊患者的信息。这些信息包括住院/门诊状态、诊断、症状和转诊医生的治疗目标;以及与医院住院患者数据相关的信息,以获取死亡日期和地点。

地点/参与者:所有血液科的转诊都来自 2007 年 1 月至 2010 年 12 月。

结果

血液科转诊占研究期间所有转诊的 11.6%。随着时间的推移,门诊转诊显著增加,转诊用于症状控制的患者比例也有所增加。从转诊到死亡的中位数时间为 34 天,急性白血病和住院患者的生存最差。总体而言,54%的住院血液科死亡患者接受了 DPPC 的咨询,这些患者在重症监护病房死亡的可能性较小。

结论

近年来,血液科和姑息治疗之间的合作导致转诊数量增加,可能对患者产生积极的结果。

相似文献

1
Palliative care and hematological malignancies: increased referrals at a comprehensive cancer centre.姑息治疗与血液系统恶性肿瘤:综合癌症中心的转诊量增加。
J Palliat Med. 2013 May;16(5):537-41. doi: 10.1089/jpm.2012.0377.
2
Palliative care for AIDS at a large urban teaching hospital: program description and preliminary outcomes.一家大型城市教学医院的艾滋病姑息治疗:项目描述与初步成果
J Palliat Med. 2003 Jun;6(3):461-74. doi: 10.1089/109662103322144844.
3
The impact of a palliative medicine consultation service in medical oncology.姑息医学咨询服务对肿瘤内科的影响。
Support Care Cancer. 2002 May;10(4):337-42. doi: 10.1007/s00520-002-0341-8. Epub 2002 Feb 15.
4
[Palliative care medical consultation in a hematology department. Feedback and critical reflection on a year of practice].[血液科的姑息治疗医学会诊。对一年实践的反馈与批判性反思]
Bull Cancer. 2020 Nov;107(11):1118-1128. doi: 10.1016/j.bulcan.2020.08.015. Epub 2020 Oct 12.
5
Timing of referral to outpatient palliative care for patients with haematologic malignancies.血液恶性肿瘤患者转至姑息治疗门诊的时机。
Br J Haematol. 2022 Sep;198(6):974-982. doi: 10.1111/bjh.18365. Epub 2022 Jul 21.
6
Validation of 2 Prognostic Models in Hospitalized Patients With Advanced Hematological Malignancies in Japan.日本晚期血液系统恶性肿瘤住院患者中两种预后模型的验证
Am J Hosp Palliat Care. 2017 Apr;34(3):258-262. doi: 10.1177/1049909115615567. Epub 2016 Jul 10.
7
Association between referral-to-death interval and location of death of patients referred to a hospital-based specialist palliative care service.转诊至死亡时间间隔与转诊至医院专科姑息治疗服务的患者死亡地点之间的关联。
J Pain Symptom Manage. 2013 Aug;46(2):173-81. doi: 10.1016/j.jpainsymman.2012.08.009. Epub 2012 Nov 21.
8
Palliative Care in Patients With Hematological Malignancies. We Have a Long Way to Go….血液恶性肿瘤患者的姑息治疗。我们还有很长的路要走....
Am J Hosp Palliat Care. 2023 Dec;40(12):1324-1330. doi: 10.1177/10499091221149150. Epub 2023 Jan 2.
9
Specialist palliative care and patients with noncancer diagnoses: the experience of a service.专科姑息治疗与非癌症诊断患者:一项服务的经验
Palliat Med. 1999 Nov;13(6):477-84. doi: 10.1191/026921699670359259.
10
Interval between palliative care referral and death among patients treated at a comprehensive cancer center.在一家综合癌症中心接受治疗的患者中,姑息治疗转诊与死亡之间的间隔时间。
J Palliat Med. 2005 Oct;8(5):1025-32. doi: 10.1089/jpm.2005.8.1025.

引用本文的文献

1
Silent Conversations: Goals of Care and End-of-Life Quality in Relapsed High-Risk Leukemia.无声的对话:复发高危白血病的照护目标与临终质量
J Adv Pract Oncol. 2023 Jul;14(5):380-387. doi: 10.6004/jadpro.2023.14.5.3. Epub 2023 Jul 1.
2
A Bibliometric Analysis and Visualization of Decision Support Systems for Healthcare Referral Strategies.决策支持系统在医疗转介策略中的应用:文献计量分析与可视化。
Int J Environ Res Public Health. 2022 Dec 16;19(24):16952. doi: 10.3390/ijerph192416952.
3
Duration of palliative care before death in international routine practice: a systematic review and meta-analysis.
国际常规实践中死亡前姑息治疗的持续时间:系统评价和荟萃分析。
BMC Med. 2020 Nov 26;18(1):368. doi: 10.1186/s12916-020-01829-x.
4
Caregivers of Patients with Hematological Malignancies within Home Care: A Phenomenological Study.血液恶性肿瘤患者家庭护理者:一项现象学研究。
Int J Environ Res Public Health. 2020 Jun 5;17(11):4036. doi: 10.3390/ijerph17114036.
5
Early palliative care versus standard care in haematologic cancer patients at their last active treatment: study protocol of a feasibility trial.早期姑息治疗与血液恶性肿瘤患者最后一次积极治疗时的标准治疗相比:一项可行性试验的研究方案。
BMC Palliat Care. 2020 Apr 22;19(1):53. doi: 10.1186/s12904-020-00561-w.
6
Palliative Care in Patients with Leukemia: When and How?白血病患者的姑息治疗:何时及如何实施?
Curr Oncol Rep. 2018 Nov 13;20(12):95. doi: 10.1007/s11912-018-0743-5.
7
Comparing the Palliative Care Needs of Patients With Hematologic and Solid Malignancies.比较血液系统恶性肿瘤和实体瘤患者的姑息治疗需求。
J Pain Symptom Manage. 2018 Jan;55(1):82-88.e1. doi: 10.1016/j.jpainsymman.2017.08.030. Epub 2017 Sep 5.
8
A systematic review of prognostic factors at the end of life for people with a hematological malignancy.对血液系统恶性肿瘤患者临终时预后因素的系统评价。
BMC Cancer. 2017 Mar 23;17(1):213. doi: 10.1186/s12885-017-3207-7.
9
Caring for terminal patients in haematology: the urgent need of a new research agenda.血液学中终末期患者的护理:新研究议程的迫切需求。
Support Care Cancer. 2015 Jan;23(1):5-7. doi: 10.1007/s00520-014-2489-4. Epub 2014 Oct 24.
10
End-of-life characteristics and palliative care provision for elderly patients suffering from acute myeloid leukemia.老年急性髓系白血病患者的临终特征及姑息治疗提供情况
Support Care Cancer. 2015 Jan;23(1):111-6. doi: 10.1007/s00520-014-2333-x. Epub 2014 Jul 5.